Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 

Nicholas Smedira, MD, a cardiovascular surgeon with Cleveland Clinic, discusses septal myectomy and the need to improve overall HCM care with new standards and evidence-based guidelines.

One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.

Researchers shared long-term follow-up data from the Colchicine-PCI trial, which compared colchicine administration before PCI with a placebo.

Tyler Shatley, a veteran offensive lineman with the Jacksonville Jaguars, said he experienced symptoms for years before finally seeking a diagnosis. 

Using these devices as part of a zero-fluoroscopy workflow, which replaces X-rays with an alternative modality such as ultrasound, limits radiation exposure and the use of burdensome protective equipment.

Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up. 

Anjali Owens, MD, discussed the past, present and future of hypertrophic cardiomyopathy care in the United States. "What we are aiming to do is develop a minimum standard for assessments of patients with HCM so they are getting properly diagnosed and managed," she explained.